Komori
Kunimine Industries (5388) · InitiativeAdvanced

Development of New Products and Applications through Industry-Academia and Corporate Collaboration

First written in FY2016. 23 of 34 entries say "Restated". Latest entry: FY2026.

34entries
11years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2019-Q1 – FY2020-Q32016: 320162017: 420172018: 420182019: 320192020: 420202021: 320212022: 420222023: 220232024: 320242025: 220252026: 22026
Same theme, other companies
Creating high-value-added products based on materials and elemental technologiesA theme 89 companies write about · 0 as a headwind · 114 as a tailwind

51 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 89 companies compared. The sentences above are computed from all 89.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「In the Clay Science business, the company continued collecting data tailored to needs for gas-barrier applications involving hydrogen, oxygen and water vapor, and made technology proposals to pursue materials development and problem-solving through collaboration with companies. Regarding the spheroid-promoting function in three-dimensional cell culture found through joint research with Osaka University, the company continued market development through reagent sales while expanding its data and exploring new functions using 2 grant-funded projects. Regarding the electrochemical properties of clay found through joint research with Yamagata University, the company continued making technology proposals based on its accumulated data and worked toward collaboration with companies. It also began materials development to expand into the polishing field.」

    Commercialization of research results and development of new applications progressed, including technology proposals for gas-barrier materials, market development for three-dimensional cell-culture reagents and 2 grant-funded projects, proposals for corporate collaboration involving electrochemical properties, and the start of materials development for the polishing field. R&D expenses were ¥235 million.
  2. 2026-05-08AdvancedEarnings

    「We will continue to focus on research and development and personnel training, while working to establish a structure for promoting DX and utilizing AI.」

    R&D expenses amounted to ¥235 million, and the company has explicitly stated that it will continue R&D while establishing a structure for utilizing AI.
  3. FY2026-H1RestatedAnnual report

    「The group's total R&D expenses for the six-month interim period were ¥127 million. There were no material changes in the status of the group's R&D activities during the six-month interim period.」

    The company stated that there had been no material changes in its R&D activities and disclosed R&D expenses of ¥127 million for the interim period.
  4. FY2025AdvancedAnnual report

    「Regarding the spheroid-promoting function in three-dimensional cell culture found through joint research with Osaka University, the company began selling reagents in May 2024 and pursued market development. It also entered the technology in the 7th Japan Open Innovation Prize and received the Minister of Education, Culture, Sports, Science and Technology Award. Regarding the electrochemical properties of clay found through joint research with Yamagata University, the company compiled its accumulated data, began making technology proposals, and worked toward collaboration with companies. R&D expenses for the fiscal year were ¥207 million.」

    Research results from industry-academia collaboration progressed to the start of reagent sales, market development, receipt of the Minister of Education, Culture, Sports, Science and Technology Award, and the start of technology proposals based on another joint research project. R&D expenses were ¥207 million.
  5. FY2025-H1RestatedAnnual report

    「The group's total R&D expenses for the six-month interim period were ¥105 million. There were no material changes in the status of the group's R&D activities during the six-month interim period.」

    The company stated that there had been no material changes in its R&D activities and disclosed R&D expenses of ¥105 million for the interim period.
  6. FY2024AdvancedAnnual report

    「In the Clay Science business, the growing market penetration of clay films prompted many downstream companies to seek barrier properties, and the company worked with them on materials development and problem-solving. For the hydrogen gas-barrier coating material developed through joint research with JAXA and the National Institute of Advanced Industrial Science and Technology, the company continued sales activities and additional data collection aimed at market development. Regarding the ISO standard for nanoclay for gas-barrier applications published in May 2021, the company applied for designation as a testing laboratory responsible for evaluating the listed requirements for practical implementation and obtained accreditation. In addition, the company prepared for commercialization in fiscal 2024 of the spheroid-promoting function in three-dimensional cell culture found through joint research with Osaka University. R&D expenses for the fiscal year were ¥176 million.」

    R&D progressed into the implementation phase, including market development for the hydrogen gas-barrier coating material, accreditation as a designated testing laboratory under the nanoclay ISO standard, and preparations to commercialize in fiscal 2024 the results of joint research with Osaka University.
  7. FY2024-Q3RestatedAnnual report

    「The group's total R&D expenses for the cumulative nine-month period were ¥136 million. There were no material changes in the status of the group's R&D activities during the cumulative nine-month period.」

    The company stated that there had been no material changes in its R&D activities and disclosed R&D expenses of ¥136 million for the cumulative nine-month period.
  8. FY2023AdvancedAnnual report

    「The joint research with JAXA and the National Institute of Advanced Industrial Science and Technology, which began in December 2021, achieved its development objectives after one year of research. The company began sales activities and additional data collection to bring the hydrogen gas-barrier coating material to market. Regarding the ISO standard for nanoclay for gas-barrier applications published in May 2021, applications opened for designated testing laboratories responsible for evaluating the standard's listed requirements, and the company submitted an application.」

    The joint research with JAXA and the National Institute of Advanced Industrial Science and Technology achieved its development objectives and moved into the market development phase for the hydrogen gas-barrier coating material. The company also began applying for designation as a testing laboratory under the nanoclay ISO standard.
  9. FY2023-Q3RestatedAnnual report

    「The group's total R&D expenses for the cumulative nine-month period were ¥122 million. There were no material changes in the status of the group's R&D activities during the cumulative nine-month period.」

    The company stated that there had been no material changes in its R&D activities and disclosed R&D expenses of ¥122 million for the cumulative nine-month period.
  10. FY2023-Q2RestatedAnnual report

    「The group's total R&D expenses for the cumulative six-month period were ¥81 million. There were no material changes in the status of the group's R&D activities during the cumulative six-month period.」

    The company stated that there had been no material changes in its R&D activities and disclosed R&D expenses of ¥81 million for the cumulative six-month period.
  11. FY2023-Q1RestatedAnnual report

    「The group's total R&D expenses for the cumulative three-month period were ¥48 million. There were no material changes in the status of the group's R&D activities during the cumulative three-month period.」

    The company stated that there had been no material changes in its R&D activities and disclosed R&D expenses of ¥48 million for the cumulative three-month period.
  12. FY2022AdvancedAnnual report

    「The company also joined a standards subcommittee to advance the international standardization of nanoclay for gas-barrier applications, leading to the publication of ISO/TS 21236-2 in May 2021. Preparations for its implementation were undertaken in parallel. In October 2021, a research project on hydrogen-barrier coating materials using the company's gas-barrier technology was selected by JAXA's Space Exploration Innovation Hub, and joint research began in December of the same year with JAXA and the National Institute of Advanced Industrial Science and Technology. R&D expenses for the fiscal year were ¥162 million.」

    The company achieved specific R&D milestones, including the publication of an ISO standard for nanoclay and the start of joint research with JAXA and the National Institute of Advanced Industrial Science and Technology on hydrogen-barrier coatings.
  13. FY2022-Q3RestatedAnnual report

    「The group's research and development expenditure for the first 9 months of the consolidated cumulative period was ¥121 million. There were no material changes in the status of the group's research and development activities during the first 9 months of the consolidated cumulative period.」

    The company stated that there had been no material changes in its R&D activities and disclosed R&D expenses of ¥121 million for the cumulative nine-month period.
  14. FY2022-Q2RestatedAnnual report

    「The group's research and development expenditure for the first half of the consolidated cumulative period was ¥85 million. There were no material changes in the status of the group's research and development activities during the first half of the consolidated cumulative period.」

    The company disclosed research and development expenditure of ¥85 million for the cumulative period through the second quarter, stating that there were no material changes in its research and development activities.
  15. FY2021AdvancedAnnual report

    「The company also participated in a standards subcommittee to advance international standardization of nanoclay for gas-barrier applications, reaching the stage where publication of the first edition of the ISO standard is expected. Research and development expenditure for the consolidated fiscal year was ¥151 million.」

    International standardization of nanoclay progressed to the stage where publication of the first edition of the ISO standard is expected. Research and development expenditure was ¥151 million.
  16. FY2021-Q3RestatedAnnual report

    「The group's research and development expenditure for the first 9 months of the consolidated cumulative period was ¥111 million. There were no material changes in the status of the group's research and development activities during the first 9 months of the consolidated cumulative period.」

    The company disclosed research and development expenditure of ¥111 million for the cumulative period through the third quarter, stating that there were no material changes in its research and development activities.
  17. FY2021-Q2RestatedAnnual report

    「The group's research and development expenditure for the first half of the consolidated cumulative period was ¥77 million. There were no material changes in the status of the group's research and development activities during the first half of the consolidated cumulative period.」

    The company disclosed research and development expenditure of ¥77 million for the cumulative period through the second quarter, stating that there were no material changes in its research and development activities.
  18. FY2021-Q1RestatedAnnual report

    「The group's research and development expenditure for the first quarter of the consolidated cumulative period was ¥40 million. There were no material changes in the status of the group's research and development activities during the first quarter of the consolidated cumulative period.」

    The company disclosed research and development expenditure of ¥40 million for the cumulative period through the first quarter, stating that there were no material changes in its research and development activities.
  19. FY2020AdvancedAnnual report

    「During the consolidated fiscal year, research and development activities focused on developing new products with a view to the future, mainly through technical cooperation and materials development involving collaboration with other fields through industry-academia and corporate partnerships. In the bentonite business, the company conducted technology development to ensure a stable supply of products for the casting, civil engineering and construction foundations, industrial waste, and geological disposal of radioactive waste fields, and to propose high-performance products tailored to market needs. It also applied existing technologies cultivated over many years and promoted joint research through industry-academia-government collaboration to prepare for entry into the production-animal medical field. Research and development expenditure for the consolidated fiscal year was ¥162 million.」

    The company continued research and development through industry-academia and corporate collaboration, considered entry into the production-animal medical field, and conducted technology development in multiple fields. Research and development expenditure was ¥162 million.
  20. FY2020-Q3RestatedAnnual report

    「The group's research and development expenditure for the first 9 months of the consolidated cumulative period was ¥117 million. There were no material changes in the status of the group's research and development activities during the first 9 months of the consolidated cumulative period.」

    The company disclosed research and development expenditure of ¥117 million for the cumulative period through the third quarter, stating that there were no material changes in its research and development activities.
  21. FY2020-Q2RestatedAnnual report

    「The group's research and development expenditure for the first half of the consolidated cumulative period was ¥72 million. There were no material changes in the status of the group's research and development activities during the first half of the consolidated cumulative period.」

    The company disclosed research and development expenditure of ¥72 million for the cumulative period through the second quarter, stating that there were no material changes in its research and development activities.
  22. FY2020-Q1RestatedAnnual report

    「The group's research and development expenditure for the first quarter of the consolidated cumulative period was ¥38 million. There were no material changes in the status of the group's research and development activities during the first quarter of the consolidated cumulative period.」

    The company disclosed research and development expenditure of ¥38 million for the cumulative period through the first quarter, stating that there were no material changes in its research and development activities.
  23. FY2019-Q3RestatedAnnual report

    「The group's research and development expenditure for the first 9 months of the consolidated cumulative period was ¥108 million. There were no material changes in the status of the group's research and development activities during the first 9 months of the consolidated cumulative period.」

    The company disclosed research and development expenditure of ¥108 million for the cumulative period through the third quarter, stating that there were no material changes in its research and development activities.
  24. FY2019-Q2RestatedAnnual report

    「The group's research and development expenditure for the first half of the consolidated cumulative period was ¥76 million. There were no material changes in the status of the group's research and development activities during the first half of the consolidated cumulative period.」

    The company disclosed research and development expenditure of ¥76 million for the cumulative period through the second quarter, stating that there were no material changes in its research and development activities.
  25. FY2019-Q1RestatedAnnual report

    「The group's research and development expenditure for the first quarter of the consolidated cumulative period was ¥40 million. There were no material changes in the status of the group's research and development activities during the first quarter of the consolidated cumulative period.」

    The company disclosed research and development expenditure of ¥40 million for the cumulative period through the first quarter, stating that there were no material changes in its research and development activities.
  26. FY2018AdvancedAnnual report

    「In the specialty chemicals business, the growing market penetration of clay films stimulated demand for barrier properties among many downstream companies, prompting initiatives for collaborative materials development and problem-solving. To meet growing demand for synthetic and purified clay, the company developed manufacturing processes to improve production efficiency. In the water-stopping materials field, it worked on an all-automatic production system and developed high-performance products using proprietary technologies. In the granulation technology field, it mainly worked to advance coating technologies and strengthen its business foundation. Research and development expenditure for the consolidated fiscal year was ¥192 million.」

    While continuing industry-academia and corporate collaboration, the company conducted specific research and development in multiple fields, including clay films, synthetic and purified clay, an all-automatic production system, water-stopping materials and granulation technology. Research and development expenditure was ¥192 million.
  27. FY2018-Q3RestatedAnnual report

    「The group's research and development expenditure for the first 9 months of the consolidated cumulative period was ¥137 million. There were no material changes in the status of the group's research and development activities during the first 9 months of the consolidated cumulative period.」

    The company disclosed research and development expenditure of ¥137 million for the cumulative period through the third quarter, stating that there were no material changes in its research and development activities.
  28. FY2018-Q2RestatedAnnual report

    「The group's research and development expenditure for the first half of the consolidated cumulative period was ¥90 million. There were no material changes in the status of the group's research and development activities during the first half of the consolidated cumulative period.」

    The company disclosed research and development expenditure of ¥90 million for the cumulative period through the quarter, stating that there were no material changes in its research and development activities.
  29. FY2018-Q1RestatedAnnual report

    「The group's research and development expenditure for the first quarter of the consolidated cumulative period was ¥40 million. There were no material changes in the status of the group's research and development activities during the first quarter of the consolidated cumulative period.」

    The company disclosed research and development expenditure of ¥40 million for the cumulative period through the quarter, stating that there were no material changes in its research and development activities.
  30. FY2017AdvancedAnnual report

    「During the consolidated fiscal year, research and development activities focused on developing new products with a view to the future, mainly through materials development involving collaboration with other fields through industry-academia and corporate partnerships. In the water-stopping materials field, the company obtained certification registration under the New Technology Information Provision System and developed high-performance products using proprietary technologies. Research and development expenditure for the consolidated fiscal year was ¥165 million.」

    The company continued industry-academia and corporate collaboration, carried out specific activities including certification registration for water-stopping materials and the development of high-performance products, and recorded research and development expenditure of ¥165 million.
  31. FY2017-Q3RestatedAnnual report

    「The group's research and development expenditure for the first 9 months of the consolidated cumulative period was ¥114 million. There were no material changes in the status of the group's research and development activities during the first 9 months of the consolidated cumulative period.」

    The company disclosed research and development expenditure of ¥114 million for the cumulative period through the quarter, stating that there were no material changes in its research and development activities.
  32. FY2017-Q2RestatedAnnual report

    「The group's research and development expenditure for the first half of the consolidated cumulative period was ¥74 million. There were no material changes in the status of the group's research and development activities during the first half of the consolidated cumulative period.」

    The company disclosed research and development expenditure of ¥74 million for the cumulative period through the quarter, stating that there were no material changes in its research and development activities.
  33. FY2017-Q1RestatedAnnual report

    「The group's research and development expenditure for the first quarter of the consolidated cumulative period was ¥41 million. There were no material changes in the status of the group's research and development activities during the first quarter of the consolidated cumulative period.」

    The company disclosed research and development expenditure of ¥41 million for the quarter, stating that there were no material changes in its research and development activities.
  34. FY2016First statedAnnual report

    「During the consolidated fiscal year, research and development activities focused on developing new products with a view to the future, mainly through materials development involving collaboration with other fields through industry-academia and corporate partnerships.」

    Research and development expenditure for the year was ¥161 million, covering clay films, synthetic clay, water-stopping materials, granulation technology and other areas.
Moved together

"Enhancing the Use of Existing Resources and Expanding Applications" moved the same way as this thread, in the same document, in 8 of its 34 moves.

854444★123456
  1. ★This thread
  2. 1Enhancing the Use of Existing Resources and Expanding Applications8×
  3. 2Reduced power consumption, labor-saving, and higher productivity5×
  4. 3Expanding orders for pesticide processing by leveraging 3 plants4×
  5. 4Delays in Passing Cost Increases Through to Prices4×
  6. 5Responding to Cost Increases Through Price Revisions4×
  7. 6Strengthening Organizational Capabilities through ESG Management and DX4×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Kunimine Industries's next results are scheduled for 2026-10-30. Read the earnings preview It last moved in the Earnings of 2026-05-08: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Development of New Products and Applications through Industry-Academia and Corporate Collaboration | KUNIMINE INDUSTRIES CO.,LTD. (5388) | Komori